-
-
-
-
-
-
-
Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company
-
-
-
-
-
-
-
Aziyo Biologics Reports Strong Third Quarter 2022 Revenue
-
-
-
-
-
-
-
Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO
-
-
-
-
-
-
-
Aziyo Biologics Reports Third Quarter 2020 Financial Results
1,157,591 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

